Hyderabad, Jan 4 (IANS) Bharat Biotech Chairman Krishna Ella said on Monday that the company does not deserve the backlash it is receiving in the light of the India's drugs regulator granting its coronavirus vaccine Covaxin approval for emergency use.
"Don't accuse us of inexperience. We are a global company... have manufactured 16 vaccines," he said, highlighting that "200 per cent honest" clinical trials were conducted.
Ella said the company conducts clinical trials not only in India but also many other countries.
His comments assume significance as Covaxin has been given an emergency approval despite allegedly only two of the required three trial phases being completed.
However, Ella pointed at the number of journal articles Bharat Biotech published and claimed that it was the first to identify Zika virus and file a patent for Zika and Chikungunya viruses.
Bharat Biotech was the only company to have a Bio Safety Level 3 (BSL- 3) production facility, he noted.
"We do 200 per cent honest clinical trials and yet we receive a backlash. If I am wrong, tell me. Some companies have branded me 'water'. I want to deny that. We are scientists," he said.
Are you an Ayurveda doctor? Download our App from Google PlayStore now!
Download NirogStreet App for Ayurveda Doctors. Discuss cases with other doctors, share insights and experiences, read research papers and case studies. Get Free Consultation 9625991603 | 9625991607 | 8595299366
New York, Jan 28 (IANS) Study so far has proved that the current vaccines remained effective against the variants of the Covid-19, which already infected over 100 million peop...
Berlin, Jan 28 (IANS) Exactly one year ago today, the first Covid-19 case in Germany was officially confirmed. Since then, more than 2.16 million Covid-19 cases have been regi...
London, Jan 28 (IANS) Another 25,308 people in Britain have tested positive for Covid-19, bringing the total number of coronavirus cases in the country to 37,15,054, according...